Works matching IS 13524585 AND DT 2014 AND VI 20 AND IP 10
Results: 25
Addressing the regulatory and scientific challenges in multiple sclerosis – a statement from the EU regulators.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 10, p. 1282, doi. 10.1177/1352458514546876
- By:
- Publication type:
- Article
NMO spectrum disorders: how wide is the spectrum?
- Published in:
- 2014
- By:
- Publication type:
- Opinion
Optical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis: Commentary.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 10, p. 1302, doi. 10.1177/1352458514545144
- By:
- Publication type:
- Article
Optical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis: No.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 10, p. 1299, doi. 10.1177/1352458514541510
- By:
- Publication type:
- Article
Optical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis: Yes.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 10, p. 1296, doi. 10.1177/1352458514541509
- By:
- Publication type:
- Article
A case of pathology-proven neuromyelitis optica spectrum disorder with Sjögren syndrome manifesting aphasia and apraxia due to a localized cerebral white matter lesion.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 10, p. 1413, doi. 10.1177/1352458514540834
- By:
- Publication type:
- Article
Sudden onset of sleep due to hypothalamic lesions in neuromyelitis optica spectrum disorder positive for anti-aquaporin-4 antibody.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 10, p. 1407, doi. 10.1177/1352458514540359
- By:
- Publication type:
- Article
A novel association of ocular neuromyotonia with brainstem demyelination: Two case reports.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Relapsing inappropriate antidiuretic hormone secretion in an anti-aquaporin-4 antibody positive paediatric patient.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 10, p. 1404, doi. 10.1177/1352458514536254
- By:
- Publication type:
- Article
Extensive cerebral white matter involvement in a patient with NMO spectrum disorder.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 10, p. 1401, doi. 10.1177/1352458514536253
- By:
- Publication type:
- Article
Natalizumab and fingolimod: Insight into their relative efficacies in clinical practice.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 10, p. 1280, doi. 10.1177/1352458514535283
- By:
- Publication type:
- Article
An observational comparison of natalizumab vs. fingolimod using JCV serology to determine therapy.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 10, p. 1381, doi. 10.1177/1352458514535282
- By:
- Publication type:
- Article
The role of microglial activation in disease progression.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 10, p. 1288, doi. 10.1177/1352458514533230
- By:
- Publication type:
- Article
Does risk stratification decrease the risk of natalizumab-associated PML? Where is the evidence?
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 10, p. 1304, doi. 10.1177/1352458514531843
- By:
- Publication type:
- Article
Combined visual and motor evoked potentials predict multiple sclerosis disability after 20 years.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 10, p. 1348, doi. 10.1177/1352458514525867
- By:
- Publication type:
- Article
MiR-126: a novel route for natalizumab action?
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 10, p. 1363, doi. 10.1177/1352458514524998
- By:
- Publication type:
- Article
Optical coherence tomography and visual evoked potentials: which is more sensitive in multiple sclerosis?
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 10, p. 1342, doi. 10.1177/1352458514524293
- By:
- Publication type:
- Article
MOG extracellular domain (p1–125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 10, p. 1312, doi. 10.1177/1352458514524086
- By:
- Publication type:
- Article
Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 10, p. 1331, doi. 10.1177/1352458514523498
- By:
- Publication type:
- Article
Differential effects of fingolimod on B-cell populations in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 10, p. 1371, doi. 10.1177/1352458514523496
- By:
- Publication type:
- Article
Investigation of outer cortical magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 10, p. 1322, doi. 10.1177/1352458514522537
- By:
- Publication type:
- Article
Neurofilament light antibodies in serum reflect response to natalizumab treatment in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 10, p. 1355, doi. 10.1177/1352458514521887
- By:
- Publication type:
- Article
Metabolomic profiling in multiple sclerosis: insights into biomarkers and pathogenesis.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 10, p. 1396, doi. 10.1177/1352458513516528
- By:
- Publication type:
- Article
Cerebrospinal fluid pleocytosis in multiple sclerosis patients with lesions showing reduced diffusion.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 10, p. 1391, doi. 10.1177/1352458513515083
- By:
- Publication type:
- Article
Risk evaluation and monitoring in multiple sclerosis therapeutics.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 10, p. 1306, doi. 10.1177/1352458513513207
- By:
- Publication type:
- Article